Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 December 2019 | Story Dr Cindé Greyling | Photo Supplied
When academics and economics meet

KovsieInnovation at the UFS is bridging the gap between industry and academics with a powerful force. For too long, research remained an academic pursuit, with many innovative ideas stuck between the pages of a thesis – only to come alive during exclusive, short-lived conference proceeds.


KovsieInnovation

Recently, Gerard Verhoef, Director in the Directorate: Research Development (DRD), and his team from KovsieInnovation finalised their Innovation and Commercialisation Strategy in order to create a structured pathway for good ideas. The primary objective of KovsieInnovation – the UFS Innovation and Entrepreneurship Office – is to achieve sustainable growth in third-stream income from innovative research activities stemming from the UFS. “Potential successful ideas must be feasible, viable, and sustainable, and we formulated an eight-step plan to facilitate this,” Verhoef explains. Ultimately, the DRD wants to attract new and continuous research as a renowned academic knowledge partner that can foster, drive, and successfully commercialise innovative research activities; and in doing so, foster an entrepreneurial culture at the UFS.


Liquid Culture

One such success story is the development of Liquid Culture into a business of choice, supplying liquid yeast to breweries and bakeries. Christopher Rothmann and Dr Errol Cason are the driving forces behind this company that produces their sought-after and stable yeast product in the Department of Microbiology, Biochemistry and Food Biotechnology at the UFS. With world-class equipment and laboratories, they house one of the largest yeast-culture collections in the world.

Both Rothman and Dr Cason were home brewers for many years before starting to produce commercial batches. They believe it would not have been possible without the help of KovsieInnovation. This project was also one of the finalists in the National Entrepreneurship Intervarsity.


Christo Strydom Nutrition (CSN)

Another innovative way in which the UFS generates third-stream income via the DRD, is by partnering with already successful commercial products. One such example is the recent successful royalty agreement with CSN. With this transaction, the university unlocked its brand potential to the benefit of both the industry partner and the UFS. Quality assurance remains the key success factor for deals like this.

News Archive

Champagne and cancer have more in common than you might think
2013-05-08

 

Photo: Supplied
08 May 2013

No, a glass of champagne will not cure cancer....

…But they have more in common than you might think.

Researchers from the Departments of Microbial Biochemical and Food Biotechnology, Physics and the Centre for Microscopy at the University of the Free State in South Africa were recently exploring the properties of yeast cells in wine and food to find out more of how yeast was able to manufacture the gas that caused bread to rise, champagne to fizz and traditional beer to foam. And the discovery they made is a breakthrough that may have enormous implications for the treatment of diseases in humans.

The team discovered that they could slice open cells with argon gas particles, and look inside. They were surprised to find a maze of tiny passages like gas chambers that allowed each cell to ‘breathe.’ It is this tiny set of ‘lungs’ that puts the bubbles in your bubbly and the bounce in your bread.

But it was the technique that the researchers used to open up the cells that caught the attention of the scientists at the Mayo Clinic (Tumor Angiogenesis and Vascular Biology Research Centre) in the US.

Using this technology, they ultimately aim to peer inside cells taken from a cancer patient to see how treatment was progressing. In this way they would be able to assist the Mayo team to target treatments more effectively, reduce dosages in order to make treatment gentler on the patient, and have an accurate view of how the cancer was being eliminated.

“Yes, we are working with the Mayo Clinic,” said Profes Lodewyk Kock from the Microbial, Biochemical and Food Biotechnology Department at the UFS.

“This technique we developed has enormous potential for cell research, whether it is for cancer treatment or any other investigation into the working of cells. Through nanotechnology, and our own invention called Auger-architectomics, we are able to see where no-one has been able to see before.”

The team of Prof Kock including Dr Chantel Swart, Kumisho Dithebe, Prof Hendrik Swart (Physics, UFS) and Prof Pieter van Wyk (Centre for Microscopy, UFS) unlocked the ‘missing link’ that explains the existence of bubbles inside yeasts, and incidentally have created a possible technique for tracking drug and chemotherapy treatment in human cells.

Their work has been published recently in FEMS Yeast Research, the leading international journal on yeast research. In addition, their discovery has been selected for display on the cover page of all 2013 issues of this journal.

One can most certainly raise a glass of champagne to celebrate that!

There are links for video lectures on the technique used and findings on the Internet at:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept